Environmental and Facilities Services

TianYu Bio-Technology

TianYu Bio-Technology released FY2026 Q1 earnings on April 29 After-Market (BJT), actual revenue CNY 153.9 M, actual EPS CNY -0.0363

TianYu Bio-Technology released FY2025 Q4 earnings on April 29 After-Market (BJT), actual revenue CNY 189.99 M, actual EPS CNY 0

TianYu Bio-Technology released FY2025 earnings on April 29 After-Market (BJT), actual revenue CNY 725.59 M, actual EPS CNY -0.3684

TianYu Bio-Technology FY2026 Q1 Earning Release on April 30 After-Market (BJT)

TianYu Bio-Technology FY2025 Annual Earnings Release on April 30, 2026 After-Market (BJT)

TianYu Bio-Technology released FY2025 Q3 earnings on October 29 After-Market BJT, actual revenue CNY 123.3 M, actual EPS CNY -0.0126

TianYu Bio-Technology released FY2025 9 Months Earnings on October 29 After-Market (BJT), with actual revenue of CNY 535.6 M and EPS of CNY -0.0055

TianYu Bio-Technology to Release FY2025 Q3 Earnings on October 30 After-Market BJT

TianYu Bio-Technology released FY2025 Semi-Annual Earnings on August 29 During-Market (BJT), Actual Revenue: CNY 412.3 M, Actual EPS: CNY 0.0373

TianYu Bio-Technology released FY2025 Q2 earnings on August 29 During-Market (BJT), actual revenue CNY 187.03 M, actual EPS CNY -0.0101

TianYu Bio-Technology to Release FY2025 Semi-Annual Earnings on August 30, 2025 (BJT)

Tianyu Bio Expects Significant Growth in Net Profit for 2025 Half Year

Tianyu Bio Announced 31,800 Head of Hog Sold in June 2025

Tianyu Biotech's Pig Sales Volume Up Year-over-Year but Down Mo-over-Mo in May

Tianyu Biological Announces April 2025 Sales Data

Tianyu Bio 2025 Q1 Earnings Report Shows 6.68% Net Profit Increase

TianYu Bio-Technology released FY2025 Q1 earnings on April 29 After-Market BJT, actual revenue CNY 225.27 M, actual EPS CNY 0.0475

TianYu Bio-Technology FY2025 Q1 Earnings Release on April 30 After-Market BJT

Tianyu Bio Revenue 802 Million with Net Loss of 107 Million in 2024

TianYu Bio-Technology released FY2024 Q4 earnings on April 15 Pre-Market (BJT), actual revenue CNY 177.03 M, actual EPS CNY -0.3927

603717

TianYu Bio-Technology announced that its revenue for the third quarter was 123 million yuan, a year-on-year decrease of 38.69%; the net loss was 12.4289 million yuan, a decrease of 7,912.82%. Revenue for the first three quarters was 536 million yuan, a year-on-year decrease of 14.23%; the net loss was 1.6109 million yuan, a decrease of 152.22%

Zhitong

TianYu Bio-Technology: Net profit loss of 12.4289 million yuan in the third quarter, a decrease of 7,912.82%

TianYu Bio-Technology announced that it plans to issue shares to specific targets to raise no more than 465 million yuan, with all proceeds after deducting issuance costs to be used for replenishing working capital and repaying debts. The issuance target is Daoyun Assets controlled by the company's actual controller, Luo Weiguo, with an issuance price of 6.55 yuan per share. The number of shares to be issued will not exceed 71.0283 million shares, and the final issuance quantity will be subject to the approval of the China Securities Regulatory Commission

TianYu Bio-Technology: Plans to issue shares to specific targets to raise no more than 465 million yuan at an issue price of 6.55 yuan per share

TianYu Bio-Technology announced that in September 2025, it sold 28,600 pigs, with sales revenue of 32.7566 million yuan, a month-on-month increase of 10.33% and 9.77%, and a year-on-year change of 38.73% and -36.47%; from January to September 2025, the cumulative sales of pigs reached 276,000, a year-on-year increase of 19.64%, with a cumulative sales revenue of 395 million yuan, a year-on-year decrease of 4.59%; by the end of September, the pig inventory was 179,800, a year-on-year increase of 12.69% and a month-on-month decrease of 0.68%

TianYu Bio-Technology: September live pig sales increased by 38.73% year-on-year

TianYu Bio-Technology Co., Ltd. recently received a first-instance court ruling requiring JuZhiYuan to provide relevant financial information within 15 days. The lawsuit aims to recover performance compensation, but due to the poor financial condition of the compensation obligor, there is significant uncertainty regarding the realization of the compensation. The company reminds investors to make cautious decisions and be aware of risks

The first-instance judgment of TianYu Bio-Technology's shareholder information rights lawsuit reveals uncertainty in the realization of performance compensation

TianYu Bio-Technology announced that in order to establish a long-term and diverse shareholder return mechanism, and to thank the vast number of shareholders for their long-term attention and support, the company will jointly carry out the "Listed Company Shareholder Festival" shareholder return activity with Zhejiang Hexin Tonghuashun Network Information Co., Ltd. The activity will take place from September 29, 2025, to October 17, 2025, at 17:00. Prizes include Linjiangxian red yeast rice wine, red yeast Danshen and Sanqi soft capsules, Jiacheng red yeast tea, and Manjianghong red yeast rice wine, among others

TianYu Bio-Technology: Launching the "Listed Company Shareholder Festival" Shareholder Feedback Activity

TianYu Bio-Technology Co., Ltd. decided at the board meeting to continue using no more than 61.5 million yuan of idle raised funds to supplement working capital, and to repay 2 million yuan in advance to the special account on September 23. The company promises to fully repay the remaining funds before the due date and will timely fulfill its information disclosure obligations

TianYu Bio-Technology repaid 2 million idle raised funds in advance and will fully repay the remaining amount before maturity

002157

300761

605296

603363

The A-share pork sector surged at the beginning of the trading session, with TianYu Bio-Technology hitting the daily limit, followed by Aonong Group, ZHENGBANG TECHNOLOGY, LIHUA, Dayu Bio, and Shennong Group rising

ZHENGBANG TECHNOLOGY

LIHUA

Shennong Group

Aonong Group

TianYu Bio-Technology sold 26,000 live pigs in August 2025, with sales revenue of 29.8423 million yuan, a month-on-month increase of 50.83% and a year-on-year increase of 2.04%. From January to August 2025, the cumulative sales of live pigs reached 247,400, a year-on-year increase of 17.77%, with a cumulative sales revenue of 362 million yuan, a year-on-year decrease of 0.05%. As of the end of August 2025, the company's live pig inventory was 181,000, a year-on-year increase of 22.29%

In August, TianYu Bio-Technology's sales revenue from live pigs was 29.8423 million yuan

002100

002385

603151

000048

Pork stocks fluctuated upward, Teamgene hit the daily limit, Aonong Group, KINGKEY SMART AGRI, TianYu Bio-Technology, TECON, and DBN Group followed suit

TECON

DBN Group

Teamgene

KINGKEY SMART AGRI

Pork stocks fluctuate upward, Teamgene hits the limit up

TianYu Bio-Technology announced that the company plans to issue shares to specific targets to raise no more than 465 million yuan. The raised funds, after deducting issuance costs, will be used entirely to replenish working capital and repay debts. The number of shares to be issued will not exceed 71.0283 million shares, and the issuance target is Daoyun Asset controlled by the company's actual controller, Luo Weiguo

TianYu Bio-Technology: Plans to issue shares to specific targets to raise no more than 465 million yuan

TianYu Bio-Technology(603717.SH)